Cost-Effectiveness of Newborn Circumcision in Reducing Lifetime HIV Risk among U.S. Males
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: HIV incidence was substantially lower among circumcised versus uncircumcised heterosexual African men in three clinical trials. Based on those findings, we modeled the potential effect of newborn male circumcision on a U.S. male's lifetime risk of HIV, including associated costs and quality-adjusted life-years saved. METHODOLOGY/PRINCIPAL FINDINGS: Given published estimates of U.S. males' lifetime HIV risk, we calculated the fraction of lifetime risk attributable to heterosexual behavior from 2005-2006 HIV surveillance data. We assumed 60% efficacy of circumcision in reducing heterosexually-acquired HIV over a lifetime, and varied efficacy in sensitivity analyses. We calculated differences in lifetime HIV risk, expected HIV treatment costs and quality-adjusted life years (QALYs) among circumcised versus uncircumcised males. The main outcome measure was cost per HIV-related QALY saved. Circumcision reduced the lifetime HIV risk among all males by 15.7% in the base case analysis, ranging from 7.9% for white males to 20.9% for black males. Newborn circumcision was a cost-saving HIV prevention intervention for all, black and Hispanic males. The net cost of newborn circumcision per QALY saved was $87,792 for white males. Results were most sensitive to the discount rate, and circumcision efficacy and cost. CONCLUSIONS/SIGNIFICANCE: Newborn circumcision resulted in lower expected HIV-related treatment costs and a slight increase in QALYs. It reduced the 1.87% lifetime risk of HIV among all males by about 16%. The effect varied substantially by race and ethnicity. Racial and ethnic groups who could benefit the most from circumcision may have least access to it due to insurance coverage and state Medicaid policies, and these financial barriers should be addressed. More data on the long-term protective effect of circumcision on heterosexual males as well as on its efficacy in preventing HIV among MSM would be useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020298 · Cited by 2,451
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., Williams, C. F., Campbell, R. T., & Ndinya-Achola, J. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60312-2 · Cited by 2,292 · cited 1×
“did not practice riskier sexual behaviors during those trials [2,3].”
BackgroundMale circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chaudhary, M. A., Chen, M. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60313-4 · Cited by 2,226 · cited 1×
“did not practice riskier sexual behaviors during those trials [2,3].”
BackgroundTASK FORCE ON CIRCUMCISION, Blank, S., Brady, M., Buerk, E., Carlo, W., Diekema, D., Freedman, A., Maxwell, L., & Wegner, S. (2012) · Pediatrics · doi:10.1542/peds.2012-1989 · Cited by 592
Braithwaite, R. S., Meltzer, D. O., King, J. T., Leslie, D., & Roberts, M. S. (2008) · Medical Care · doi:10.1097/mlr.0b013e31815c31a7 · Cited by 579 · cited 1×
“A more recent analysis of society’s current willingness to pay for an extra year of life suggested a range of $183,000 to $264,000 [32].”
BackgroundMale circumcision for the prevention of HSV-2 and HPV infections and syphilis.
Tobian, A. A. R., Serwadda, D., Quinn, T. C., Kigozi, G., Gravitt, P. E., Laeyendecker, O., Charvat, B., Ssempijja, V., Riedesel, M., Oliver, A. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802556 · Cited by 512
Buchbinder, S. P., Vittinghoff, E., Heagerty, P. J., Celum, C. L., Seage, G. R., Judson, F. N., McKirnan, D., Mayer, K. H., & Koblin, B. A. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000134740.41585.f4 · Cited by 230
Sobngwi‐Tambekou, J., Taljaard, D., Lissouba, P., Zarca, K., Puren, A., Lagarde, E., & Auvert, B. (2009) · The Journal of Infectious Diseases · doi:10.1086/597208 · Cited by 142 · cited 1×
“Subsequent multivariate analyses of the South African trial data found a 34% decrease in the incidence of HSV-2 over 21 months among circumcised compared with uncircumcised males [45].”
Method
Cited by
TASK FORCE ON CIRCUMCISION, Blank, S., Brady, M., Buerk, E., Carlo, W., Diekema, D., Freedman, A., Maxwell, L., & Wegner, S. (2012) · Pediatrics · doi:10.1542/peds.2012-1990 · Cited by 337
The Medical Benefits of Male Circumcision
Tobian, A. A. R., & Gray, R. H. (2011) · JAMA · doi:10.1001/jama.2011.1431 · Cited by 120
“timated to be cost-saving due to reduced HIV infections and subsequent treatment costs.(6) If protection from genital her-”
BackgroundKlausner, J. D., & Morris, B. J. (2012) · JAMA · doi:10.1001/jama.2012.60 · Cited by 3
Newborn Circumcision: Ensuring Universal Access
Klausner, J. D. (2013) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000431046.28649.23 · Cited by 3
Metadata
- Authors
- Sansom, S. L., Prabhu, V. S., Hutchinson, A. B., An, Q., Hall, H. I., Shrestha, R. K., Lasry, A., & Taylor, A. W.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-18
- Volume
- 5
- Issue
- 1
- Pages
- e8723
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2124159391
- Cited by
- 81
- References
- 8
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.